false--12-31Q1202000000752524200000P91DP91D0.0036580004302000310000024571800025405400021015000239710000.00250.00252222000000002000000006284300062885000628430006288500015000000.00250.00125690004400000
0000075252
2020-01-01
2020-03-31
0000075252
2020-04-30
0000075252
2019-01-01
2019-03-31
0000075252
2020-03-31
0000075252
2019-12-31
0000075252
2018-12-31
0000075252
2019-03-31
0000075252
us-gaap:CommonStockMember
2019-03-31
0000075252
us-gaap:AdditionalPaidInCapitalMember
2018-07-01
2018-09-30
0000075252
us-gaap:AdditionalPaidInCapitalMember
2020-03-31
0000075252
us-gaap:CommonStockMember
2018-07-01
2018-09-30
0000075252
us-gaap:CommonStockMember
2019-01-01
2019-03-31
0000075252
us-gaap:CommonStockMember
2020-03-31
0000075252
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2019-03-31
0000075252
us-gaap:RetainedEarningsMember
2019-01-01
2019-03-31
0000075252
us-gaap:CommonStockMember
2018-12-31
0000075252
us-gaap:CommonStockMember
2019-12-31
0000075252
us-gaap:AdditionalPaidInCapitalMember
2019-01-01
2019-03-31
0000075252
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2019-01-01
2019-03-31
0000075252
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2020-03-31
0000075252
us-gaap:RetainedEarningsMember
2020-03-31
0000075252
us-gaap:RetainedEarningsMember
2019-03-31
0000075252
us-gaap:RetainedEarningsMember
2020-01-01
2020-03-31
0000075252
us-gaap:AdditionalPaidInCapitalMember
2019-03-31
0000075252
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2018-12-31
0000075252
us-gaap:AdditionalPaidInCapitalMember
2018-12-31
0000075252
us-gaap:RetainedEarningsMember
2018-12-31
0000075252
us-gaap:DiscontinuedOperationsHeldforsaleMember
omi:MoviantoMember
2020-01-01
2020-03-31
0000075252
us-gaap:DiscontinuedOperationsHeldforsaleMember
omi:MoviantoMember
2019-01-01
2019-03-31
0000075252
us-gaap:DiscontinuedOperationsHeldforsaleMember
omi:MoviantoMember
2020-01-16
0000075252
us-gaap:DiscontinuedOperationsHeldforsaleMember
omi:MoviantoMember
2019-01-01
2019-12-31
0000075252
us-gaap:DiscontinuedOperationsHeldforsaleMember
omi:MoviantoMember
2020-03-31
0000075252
us-gaap:DiscontinuedOperationsHeldforsaleMember
omi:MoviantoMember
2019-12-31
0000075252
omi:GlobalSolutionsMember
2020-03-31
0000075252
omi:GlobalProductsMember
2020-03-31
0000075252
omi:GlobalSolutionsMember
2019-12-31
0000075252
omi:GlobalSolutionsMember
2020-01-01
2020-03-31
0000075252
omi:GlobalProductsMember
2019-12-31
0000075252
omi:GlobalProductsMember
2020-01-01
2020-03-31
0000075252
us-gaap:CustomerRelationshipsMember
2020-03-31
0000075252
us-gaap:OtherIntangibleAssetsMember
2020-03-31
0000075252
us-gaap:OtherIntangibleAssetsMember
2020-01-01
2020-03-31
0000075252
us-gaap:TradeNamesMember
2020-03-31
0000075252
us-gaap:TradeNamesMember
2020-01-01
2020-03-31
0000075252
us-gaap:TradeNamesMember
2019-01-01
2019-12-31
0000075252
us-gaap:OtherIntangibleAssetsMember
2019-12-31
0000075252
us-gaap:CustomerRelationshipsMember
2019-12-31
0000075252
us-gaap:OtherIntangibleAssetsMember
2019-01-01
2019-12-31
0000075252
us-gaap:TradeNamesMember
2019-12-31
0000075252
us-gaap:CustomerRelationshipsMember
2019-01-01
2019-12-31
0000075252
us-gaap:CustomerRelationshipsMember
2020-01-01
2020-03-31
0000075252
omi:HalyardsHealthAndITSystemMember
2020-01-01
2020-03-31
0000075252
omi:GlobalProductsMember
2019-01-01
2019-03-31
0000075252
omi:GlobalSolutionsMember
2019-01-01
2019-03-31
0000075252
us-gaap:OtherRestructuringMember
2019-01-01
2019-03-31
0000075252
omi:InformationSystemCostsMember
2019-01-01
2019-03-31
0000075252
omi:EmployeeSeveranceAndOtherCostMember
2020-01-01
2020-03-31
0000075252
omi:EmployeeSeveranceAndOtherCostMember
2019-01-01
2019-03-31
0000075252
omi:InformationSystemCostsMember
2020-01-01
2020-03-31
0000075252
us-gaap:OtherRestructuringMember
2020-01-01
2020-03-31
0000075252
omi:HalyardsHealthAndITSystemMember
2019-01-01
2019-03-31
0000075252
us-gaap:CarryingReportedAmountFairValueDisclosureMember
2019-12-31
0000075252
us-gaap:EstimateOfFairValueFairValueDisclosureMember
2020-03-31
0000075252
omi:TermALoanMember
us-gaap:EstimateOfFairValueFairValueDisclosureMember
omi:TermLoanMember
2019-12-31
0000075252
omi:A4.375SeniorNotesMember
us-gaap:EstimateOfFairValueFairValueDisclosureMember
us-gaap:SeniorNotesMember
2020-03-31
0000075252
us-gaap:CarryingReportedAmountFairValueDisclosureMember
2020-03-31
0000075252
omi:AccountsReceivableSecuritizationProgramMember
us-gaap:EstimateOfFairValueFairValueDisclosureMember
us-gaap:SecuredDebtMember
2019-12-31
0000075252
us-gaap:RevolvingCreditFacilityMember
us-gaap:EstimateOfFairValueFairValueDisclosureMember
us-gaap:RevolvingCreditFacilityMember
2020-03-31
0000075252
omi:A4.375SeniorNotesMember
us-gaap:CarryingReportedAmountFairValueDisclosureMember
us-gaap:SeniorNotesMember
2020-03-31
0000075252
us-gaap:EstimateOfFairValueFairValueDisclosureMember
2019-12-31
0000075252
omi:FinanceLeaseLiabilitiesAndOtherMember
us-gaap:EstimateOfFairValueFairValueDisclosureMember
2019-12-31
0000075252
omi:TermBLoansMember
us-gaap:EstimateOfFairValueFairValueDisclosureMember
omi:TermLoanMember
2020-03-31
0000075252
omi:TermBLoansMember
us-gaap:EstimateOfFairValueFairValueDisclosureMember
omi:TermLoanMember
2019-12-31
0000075252
omi:A3.875SeniorNotesMember
us-gaap:EstimateOfFairValueFairValueDisclosureMember
us-gaap:SeniorNotesMember
2019-12-31
0000075252
omi:A3.875SeniorNotesMember
us-gaap:CarryingReportedAmountFairValueDisclosureMember
us-gaap:SeniorNotesMember
2020-03-31
0000075252
omi:TermBLoansMember
us-gaap:CarryingReportedAmountFairValueDisclosureMember
omi:TermLoanMember
2019-12-31
0000075252
us-gaap:RevolvingCreditFacilityMember
us-gaap:CarryingReportedAmountFairValueDisclosureMember
us-gaap:RevolvingCreditFacilityMember
2020-03-31
0000075252
us-gaap:RevolvingCreditFacilityMember
us-gaap:CarryingReportedAmountFairValueDisclosureMember
us-gaap:RevolvingCreditFacilityMember
2019-12-31
0000075252
omi:TermBLoansMember
us-gaap:CarryingReportedAmountFairValueDisclosureMember
omi:TermLoanMember
2020-03-31
0000075252
omi:TermALoanMember
us-gaap:EstimateOfFairValueFairValueDisclosureMember
omi:TermLoanMember
2020-03-31
0000075252
us-gaap:RevolvingCreditFacilityMember
us-gaap:EstimateOfFairValueFairValueDisclosureMember
us-gaap:RevolvingCreditFacilityMember
2019-12-31
0000075252
omi:AccountsReceivableSecuritizationProgramMember
us-gaap:EstimateOfFairValueFairValueDisclosureMember
us-gaap:SecuredDebtMember
2020-03-31
0000075252
omi:FinanceLeaseLiabilitiesAndOtherMember
us-gaap:EstimateOfFairValueFairValueDisclosureMember
2020-03-31
0000075252
omi:A3.875SeniorNotesMember
us-gaap:EstimateOfFairValueFairValueDisclosureMember
us-gaap:SeniorNotesMember
2020-03-31
0000075252
omi:FinanceLeaseLiabilitiesAndOtherMember
us-gaap:CarryingReportedAmountFairValueDisclosureMember
2020-03-31
0000075252
omi:AccountsReceivableSecuritizationProgramMember
us-gaap:CarryingReportedAmountFairValueDisclosureMember
us-gaap:SecuredDebtMember
2020-03-31
0000075252
omi:TermALoanMember
us-gaap:CarryingReportedAmountFairValueDisclosureMember
omi:TermLoanMember
2019-12-31
0000075252
omi:TermALoanMember
us-gaap:CarryingReportedAmountFairValueDisclosureMember
omi:TermLoanMember
2020-03-31
0000075252
omi:FinanceLeaseLiabilitiesAndOtherMember
us-gaap:CarryingReportedAmountFairValueDisclosureMember
2019-12-31
0000075252
omi:A4.375SeniorNotesMember
us-gaap:CarryingReportedAmountFairValueDisclosureMember
us-gaap:SeniorNotesMember
2019-12-31
0000075252
omi:AccountsReceivableSecuritizationProgramMember
us-gaap:CarryingReportedAmountFairValueDisclosureMember
us-gaap:SecuredDebtMember
2019-12-31
0000075252
omi:A3.875SeniorNotesMember
us-gaap:CarryingReportedAmountFairValueDisclosureMember
us-gaap:SeniorNotesMember
2019-12-31
0000075252
omi:A4.375SeniorNotesMember
us-gaap:EstimateOfFairValueFairValueDisclosureMember
us-gaap:SeniorNotesMember
2019-12-31
0000075252
omi:A2024NotesMember
us-gaap:SeniorNotesMember
2020-01-01
2020-03-31
0000075252
omi:EuropeanLeaseAgreementMember
omi:ReplacedLineOfCreditMember
2020-03-31
0000075252
srt:MaximumMember
omi:AccountsReceivableSecuritizationProgramMember
2020-02-19
0000075252
us-gaap:LetterOfCreditMember
2019-12-31
0000075252
us-gaap:RevolvingCreditFacilityMember
2020-03-31
0000075252
us-gaap:RevolvingCreditFacilityMember
us-gaap:EurodollarMember
2020-01-01
2020-03-31
0000075252
omi:A2021NotesMember
us-gaap:SeniorNotesMember
2020-03-31
0000075252
omi:TermBLoansMember
us-gaap:EurodollarMember
2020-01-01
2020-03-31
0000075252
omi:A2021NotesMember
us-gaap:SeniorNotesMember
2020-01-01
2020-03-31
0000075252
omi:A2024NotesMember
us-gaap:SeniorNotesMember
2020-03-31
0000075252
us-gaap:RevolvingCreditFacilityMember
2019-12-31
0000075252
us-gaap:SeniorNotesMember
2020-03-31
0000075252
omi:TermBLoansMember
us-gaap:BaseRateMember
2020-01-01
2020-03-31
0000075252
us-gaap:LetterOfCreditMember
2020-03-31
0000075252
omi:TermLoanMember
2020-03-31
0000075252
srt:MaximumMember
omi:AccountsReceivableSecuritizationProgramMember
2020-02-29
0000075252
omi:A2021and2024NotesMember
us-gaap:SeniorNotesMember
2020-01-01
2020-03-31
0000075252
us-gaap:SeniorNotesMember
2019-12-31
0000075252
omi:TermA2LoanMember
2020-01-01
2020-03-31
0000075252
omi:TermBLoansMember
2020-01-01
2020-03-31
0000075252
omi:EuropeanLeaseAgreementMember
omi:ReplacedLineOfCreditMember
2019-12-31
0000075252
srt:MaximumMember
us-gaap:RevolvingCreditFacilityMember
2020-01-01
2020-03-31
0000075252
srt:MinimumMember
us-gaap:RevolvingCreditFacilityMember
2020-01-01
2020-03-31
0000075252
us-gaap:SeniorNotesMember
2020-01-01
2020-03-31
0000075252
us-gaap:InterestRateSwapMember
us-gaap:InterestExpenseMember
2020-01-01
2020-03-31
0000075252
us-gaap:InterestRateSwapMember
2020-01-01
2020-03-31
0000075252
us-gaap:OtherLiabilitiesMember
us-gaap:InterestRateSwapMember
us-gaap:CashFlowHedgingMember
us-gaap:DesignatedAsHedgingInstrumentMember
2019-12-31
0000075252
us-gaap:InterestRateSwapMember
us-gaap:CashFlowHedgingMember
us-gaap:DesignatedAsHedgingInstrumentMember
2019-12-31
0000075252
us-gaap:OtherAssetsMember
us-gaap:InterestRateSwapMember
us-gaap:CashFlowHedgingMember
us-gaap:DesignatedAsHedgingInstrumentMember
2019-12-31
0000075252
us-gaap:OtherAssetsMember
us-gaap:InterestRateSwapMember
us-gaap:CashFlowHedgingMember
us-gaap:DesignatedAsHedgingInstrumentMember
2020-03-31
0000075252
us-gaap:OtherAssetsMember
us-gaap:ForeignExchangeContractMember
us-gaap:CashFlowHedgingMember
us-gaap:NotDesignatedAsHedgingInstrumentEconomicHedgeMember
2020-03-31
0000075252
us-gaap:OtherLiabilitiesMember
us-gaap:InterestRateSwapMember
us-gaap:CashFlowHedgingMember
us-gaap:DesignatedAsHedgingInstrumentMember
2020-03-31
0000075252
us-gaap:OtherLiabilitiesMember
us-gaap:ForeignExchangeContractMember
us-gaap:CashFlowHedgingMember
us-gaap:NotDesignatedAsHedgingInstrumentEconomicHedgeMember
2020-03-31
0000075252
us-gaap:InterestRateSwapMember
us-gaap:CashFlowHedgingMember
us-gaap:DesignatedAsHedgingInstrumentMember
2020-03-31
0000075252
us-gaap:ForeignExchangeContractMember
us-gaap:CashFlowHedgingMember
us-gaap:NotDesignatedAsHedgingInstrumentEconomicHedgeMember
2020-03-31
0000075252
us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember
2019-01-01
2019-03-31
0000075252
us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember
2019-01-01
2019-03-31
0000075252
us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember
2019-03-31
0000075252
us-gaap:AccumulatedTranslationAdjustmentMember
2019-01-01
2019-03-31
0000075252
us-gaap:AccumulatedTranslationAdjustmentMember
2018-12-31
0000075252
us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember
2019-03-31
0000075252
us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember
2018-12-31
0000075252
us-gaap:AccumulatedTranslationAdjustmentMember
2019-03-31
0000075252
us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember
2018-12-31
0000075252
us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember
2020-01-01
2020-03-31
0000075252
us-gaap:AccumulatedTranslationAdjustmentMember
2020-01-01
2020-03-31
0000075252
us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember
2019-12-31
0000075252
us-gaap:AccumulatedTranslationAdjustmentMember
2020-03-31
0000075252
us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember
2020-01-01
2020-03-31
0000075252
us-gaap:AccumulatedTranslationAdjustmentMember
2019-12-31
0000075252
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2019-12-31
0000075252
us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember
2019-12-31
0000075252
us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember
2020-03-31
0000075252
us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember
2020-03-31
0000075252
country:US
2019-01-01
2019-03-31
0000075252
country:US
2020-01-01
2020-03-31
0000075252
us-gaap:NonUsMember
2019-01-01
2019-03-31
0000075252
us-gaap:NonUsMember
2020-01-01
2020-03-31
0000075252
us-gaap:OperatingSegmentsMember
2020-01-01
2020-03-31
0000075252
us-gaap:OperatingSegmentsMember
omi:GlobalProductsMember
2019-01-01
2019-03-31
0000075252
us-gaap:OperatingSegmentsMember
omi:GlobalSolutionsMember
2019-01-01
2019-03-31
0000075252
us-gaap:OperatingSegmentsMember
omi:GlobalProductsMember
2020-01-01
2020-03-31
0000075252
us-gaap:IntersegmentEliminationMember
omi:GlobalProductsMember
2019-01-01
2019-03-31
0000075252
us-gaap:MaterialReconcilingItemsMember
2019-01-01
2019-03-31
0000075252
us-gaap:OperatingSegmentsMember
omi:GlobalSolutionsMember
2020-01-01
2020-03-31
0000075252
us-gaap:IntersegmentEliminationMember
2019-01-01
2019-03-31
0000075252
us-gaap:IntersegmentEliminationMember
2020-01-01
2020-03-31
0000075252
us-gaap:MaterialReconcilingItemsMember
2020-01-01
2020-03-31
0000075252
us-gaap:IntersegmentEliminationMember
omi:GlobalProductsMember
2020-01-01
2020-03-31
0000075252
us-gaap:OperatingSegmentsMember
2019-01-01
2019-03-31
0000075252
us-gaap:OperatingSegmentsMember
2019-12-31
0000075252
us-gaap:OperatingSegmentsMember
omi:GlobalSolutionsMember
2020-03-31
0000075252
us-gaap:OperatingSegmentsMember
2020-03-31
0000075252
us-gaap:OperatingSegmentsMember
omi:GlobalSolutionsMember
2019-12-31
0000075252
us-gaap:OperatingSegmentsMember
omi:GlobalProductsMember
2020-03-31
0000075252
us-gaap:OperatingSegmentsMember
omi:GlobalProductsMember
2019-12-31
iso4217:USD
xbrli:shares
xbrli:shares
iso4217:USD
xbrli:pure
omi:segment
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
________________________________________________
FORM 10-Q
________________________________________________
|
| |
☒ | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the quarterly period ended March 31, 2020
OR
|
| |
☐ | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
For the transition period from to
Commission file number 1-9810
_______________________________________________________
Owens & Minor, Inc.
(Exact name of Registrant as specified in its charter)
_______________________________________________________
|
| | | |
Virginia | | | 54-1701843 |
(State or other jurisdiction of incorporation or organization) | | | (I.R.S. Employer Identification No.) |
| | | |
9120 Lockwood Boulevard | Mechanicsville | Virginia | 23116 |
(Address of principal executive offices) | (Zip Code) |
| | | |
Post Office Box 27626, Richmond, Virginia | | | 23261-7626 |
(Mailing address of principal executive offices) | | | (Zip Code) |
Registrant’s telephone number, including area code (804) 723-7000
Securities registered pursuant to Section 12(b) of the Act:
|
| | | | |
Title of each class | | Trading Symbol(s) | | Name of each exchange on which registered |
Common Stock, $2 par value per share | | OMI | | New York Stock Exchange |
_________________________________________________________
Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes ☒ No ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “larger accelerated filer”, “accelerated filer”, “smaller reporting company” and "emerging growth company" in Rule 12b-2 of the Exchange Act.
|
| | | |
Large accelerated filer | ☐ | Accelerated filer | ☒ |
Non-accelerated filer | ☐ (Do not check if a smaller reporting company) | Smaller reporting company | ☒ |
Emerging growth company | ☐ | | |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. | ☐ |
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒
The number of shares of Owens & Minor, Inc.’s common stock outstanding as of April 30, 2020, was 63,007,803 shares.
Owens & Minor, Inc. and Subsidiaries
Index
|
| | |
| Page |
| | |
Item 1. | | |
| | |
| | |
| | |
| | |
| | |
| | |
Item 2. | | |
Item 3. | | |
Item 4. | | |
| |
| | |
Item 1. | | |
Item 1A. | | |
Item 6. | | |
Part I. Financial Information
Item 1. Financial Statements
Owens & Minor, Inc. and Subsidiaries
Consolidated Statements of Operations
(unaudited)
|
| | | | | | | | | |
| | Three Months Ended March 31, | |
(in thousands, except per share data) | | 2020 | | 2019 | |
Net revenue | | $ | 2,122,693 |
| | $ | 2,350,840 |
| |
Cost of goods sold | | 1,854,134 |
| | 2,074,219 |
| |
Gross margin |
| 268,559 |
| | 276,621 |
| |
Distribution, selling and administrative expenses | | 254,048 |
| | 255,112 |
| |
Acquisition-related and exit and realignment charges | | 6,064 |
| | 4,863 |
| |
Other operating (income) expense, net | | (2,309 | ) | | 42 |
| |
Operating income | | 10,756 |
| | 16,604 |
| |
Interest expense, net | | 23,342 |
| | 25,458 |
| |
Other expense, net | | 4,846 |
| | 2,734 |
| |
Loss from continuing operations before income taxes | | (17,432 | ) | | (11,588 | ) | |
Income tax benefit | | (8,523 | ) | | (670 | ) | |
Loss from continuing operations, net of tax | | (8,909 | ) | | (10,918 | ) | |
Loss from discontinued operations, net of tax | | (2,415 | ) | | (3,178 | ) | |
Net loss | | $ | (11,324 | ) | | $ | (14,096 | ) | |
| | | | | |
Loss from continuing operations per common share: basic and diluted | | $ | (0.15 | ) | | $ | (0.18 | ) | |
Loss from discontinued operations per common share: basic and diluted | | (0.04 | ) | | (0.05 | ) | |
Net loss per common share: basic and diluted | | $ | (0.19 | ) | | $ | (0.23 | ) | |
See accompanying notes to consolidated financial statements.
3
Owens & Minor, Inc. and Subsidiaries
Consolidated Statements of Comprehensive Loss
(unaudited)
|
| | | | | | | | | |
| | Three Months Ended March 31, | |
(in thousands) | | 2020 |
| 2019 | |
Net loss | | $ | (11,324 | ) | | $ | (14,096 | ) | |
Other comprehensive loss, net of tax: | | | | | |
Currency translation adjustments (net of income tax of $0 in 2020 and 2019) | | (28,178 | ) | | (4,207 | ) | |
Change in unrecognized net periodic pension costs (net of income tax of $44 in 2020 and $69 in 2019) | | 170 |
| | 197 |
| |
Net unrealized loss on derivative instruments and other (net of income tax benefit of $4,302 in 2020 and $658 in 2019) | | (11,397 | ) | | (2,413 | ) | |
Other comprehensive loss | | (39,405 | ) | | (6,423 | ) | |
Comprehensive loss | | $ | (50,729 | ) | | $ | (20,519 | ) | |
See accompanying notes to consolidated financial statements.
4
Owens & Minor, Inc. and Subsidiaries
Consolidated Balance Sheets
(unaudited)
|
| | | | | | | |
| March 31, | | December 31, |
(in thousands, except per share data) | 2020 | | 2019 |
Assets | | | |
Current assets | | | |
Cash and cash equivalents | $ | 92,315 |
| | $ | 67,030 |
|
Accounts receivable, net of allowances of $23,971 and $21,015 | 667,607 |
| | 674,706 |
|
Merchandise inventories | 1,108,844 |
| | 1,146,192 |
|
Other current assets | 151,635 |
| | 79,372 |
|
Current assets of discontinued operations | 499,410 |
| | 439,983 |
|
Total current assets | 2,519,811 |
| | 2,407,283 |
|
Property and equipment, net of accumulated depreciation of $254,054 and $245,718 | 301,335 |
| | 315,427 |
|
Operating lease assets | 133,738 |
| | 142,219 |
|
Goodwill | 388,000 |
| | 393,181 |
|
Intangible assets, net | 271,513 |
| | 285,018 |
|
Other assets, net | 100,473 |
| | 99,956 |
|
Total assets | $ | 3,714,870 |
| | $ | 3,643,084 |
|
Liabilities and equity | | | |
Current liabilities | | | |
Accounts payable | $ | 891,542 |
| | $ | 808,035 |
|
Accrued payroll and related liabilities | 44,722 |
| | 53,584 |
|
Other current liabilities | 229,824 |
| | 231,029 |
|
Current liabilities of discontinued operations | 383,586 |
| | 323,511 |
|
Total current liabilities | 1,549,674 |
| | 1,416,159 |
|
Long-term debt, excluding current portion | 1,484,340 |
| | 1,508,415 |
|
Operating lease liabilities, excluding current portion | 109,381 |
| | 117,080 |
|
Deferred income taxes | 42,962 |
| | 40,550 |
|
Other liabilities | 112,175 |
| | 98,726 |
|
Total liabilities | 3,298,532 |
| | 3,180,930 |
|
Commitments and contingencies |
| |
|
Equity | | | |
Common stock, par value $2 per share; authorized - 200,000 shares; issued and outstanding - 62,885 shares and 62,843 shares | 125,770 |
| | 125,686 |
|
Paid-in capital | 256,357 |
| | 251,401 |
|
Retained earnings | 126,323 |
| | 137,774 |
|
Accumulated other comprehensive loss | (92,112 | ) | | (52,707 | ) |
Total equity | 416,338 |
| | 462,154 |
|
Total liabilities and equity | $ | 3,714,870 |
| | $ | 3,643,084 |
|
See accompanying notes to consolidated financial statements.
5
Owens & Minor, Inc. and Subsidiaries
Consolidated Statements of Cash Flows
(unaudited)
|
| | | | | | | |
| Three Months Ended March 31, |
(in thousands) | 2020 | | 2019 |
Operating activities: | | | |
Net loss | $ | (11,324 | ) | | $ | (14,096 | ) |
Adjustments to reconcile net loss to cash provided by (used for) operating activities: | | |
|
Depreciation and amortization | 23,913 |
| | 28,720 |
|
Share-based compensation expense | 3,941 |
| | 4,505 |
|
Impairment charges | 9,080 |
| | — |
|
Provision for losses on accounts receivable | 5,213 |
| | 3,619 |
|
Deferred income tax expense (benefit) | 6,348 |
| | (8,613 | ) |
Changes in operating lease right-of-use assets and lease liabilities | (714 | ) |
| (190 | ) |
Changes in operating assets and liabilities: | | |
|
Accounts receivable | (7,942 | ) | | (22,573 | ) |
Merchandise inventories | 39,340 |
| | 80,194 |
|
Accounts payable | 98,743 |
| | (120,480 | ) |
Net change in other assets and liabilities | (77,178 | ) | | (15,668 | ) |
Other, net | 4,034 |
| | 3,678 |
|
Cash provided by (used for) operating activities | 93,454 |
| | (60,904 | ) |
Investing activities: | | | |
Additions to property and equipment | (4,771 | ) | | (11,674 | ) |
Additions to computer software | (942 | ) | | (2,605 | ) |
Proceeds from sale of property and equipment | 33 |
| | 271 |
|
Cash used for investing activities | (5,680 | ) | | (14,008 | ) |
Financing activities: | | | |
Proceeds from issuance of debt | 150,000 |
| | — |
|
(Repayments) borrowings under revolving credit facility | (6,200 | ) | | 72,100 |
|
Repayments of debt | (166,798 | ) | | (12,394 | ) |
Financing costs paid | (5,785 | ) | | (4,313 | ) |
Cash dividends paid | (155 | ) | | (4,764 | ) |
Other, net | (2,468 | ) | | (1,124 | ) |
Cash (used for) provided by financing activities | (31,406 | ) | | 49,505 |
|
Effect of exchange rate changes on cash and cash equivalents | (62 | ) | | (2,721 | ) |
Net increase (decrease) in cash, cash equivalents and restricted cash | 56,306 |
| | (28,128 | ) |
Cash, cash equivalents and restricted cash at beginning of period | 84,687 |
| | 103,367 |
|
Cash, cash equivalents and restricted cash at end of period | $ | 140,993 |
| | $ | 75,239 |
|
Supplemental disclosure of cash flow information: | | | |
Income taxes paid (received), net of refunds | $ | 2,695 |
| | $ | (12,388 | ) |
Interest paid | $ | 21,431 |
| | $ | 24,504 |
|
See accompanying notes to consolidated financial statements.
6
Owens & Minor, Inc. and Subsidiaries
Consolidated Statements of Changes in Equity
(unaudited)
|
| | | | | | | | | | | | | | | | | | | | | | |
(in thousands, except per share data) | Common Shares Outstanding | | Common Stock ($2 par value ) | | Paid-In Capital | | Retained Earnings | | Accumulated Other Comprehensive Loss | | Total Equity |
Balance, December 31, 2018 | 62,294 |
| | $ | 124,588 |
| | $ | 238,773 |
| | $ | 200,670 |
| | $ | (45,612 | ) | | $ | 518,419 |
|
Net loss | | | | | | | (14,096 | ) | | | | (14,096 | ) |
Other comprehensive loss | | | | | | | | | (6,423 | ) | | (6,423 | ) |
Dividends declared ($0.0025 per share) | | | | | | | (119 | ) | | | | (119 | ) |
Share-based compensation expense, exercises and other | 642 |
| | 1,284 |
| | 2,774 |
| |
|
| | | | 4,058 |
|
Balance, March 31, 2019 | 62,936 |
| | $ | 125,872 |
| | $ | 241,547 |
| | $ | 186,455 |
| | $ | (52,035 | ) | | $ | 501,839 |
|
| | | | | | | | | | | |
Balance, December 31, 2019 | 62,843 |
| | $ | 125,686 |
| | $ | 251,401 |
| | $ | 137,774 |
| | $ | (52,707 | ) | | $ | 462,154 |
|
Net loss | | | | | | | (11,324 | ) | | | | (11,324 | ) |
Other comprehensive loss | | | | | | | | | (39,405 | ) | | (39,405 | ) |
Dividends declared ($0.0025 per share) | | | | | | | (127 | ) | | | | (127 | ) |
Share-based compensation expense, exercises and other | 42 |
| | 84 |
| | 4,956 |
| | | | | | 5,040 |
|
Balance, March 31, 2020 | 62,885 |
| | $ | 125,770 |
| | $ | 256,357 |
| | $ | 126,323 |
| | $ | (92,112 | ) | | $ | 416,338 |
|
See accompanying notes to consolidated financial statements.
7
Owens & Minor, Inc. and Subsidiaries
Notes to Consolidated Financial Statements
(unaudited)
(in thousands, unless otherwise indicated)
Note 1—Summary of Significant Accounting Policies
Basis of Presentation
The accompanying unaudited consolidated financial statements include the accounts of Owens & Minor, Inc. and the subsidiaries it controls (we, us, our or the Company) and contain all adjustments (which are comprised only of normal recurring accruals and use of estimates) necessary to conform with U.S. generally accepted accounting principles (GAAP). All significant intercompany accounts and transactions have been eliminated. The Movianto business represents a component that met accounting requirements to be classified as discontinued operations and held for sale beginning December 31, 2019. In accordance with GAAP, the financial position and results of operations of the Movianto business are presented as discontinued operations and, as such, have been excluded from continuing operations for all periods presented. With the exception of Note 3, the Notes to the Consolidated Financial Statements reflect the continuing operations of Owens & Minor, Inc. See Note 3 for additional information regarding discontinued operations. The results of operations for interim periods are not necessarily indicative of the results expected for the full year.
Reclassifications
Certain prior year amounts have been reclassified to conform to the current year presentation.
Use of Estimates
The preparation of consolidated financial statements in conformity with GAAP requires us to make assumptions and estimates that affect reported amounts and related disclosures. Actual results may differ from these estimates.
Cash, Cash Equivalents and Restricted Cash
Cash, cash equivalents and restricted cash includes cash and marketable securities with an original maturity or maturity at acquisition of three months or less. Cash, cash equivalents and restricted cash are stated at cost. Nearly all of our cash, cash equivalents and restricted cash are held in cash depository accounts in major banks in the United States, Europe, and Asia. Cash that is held by a major bank and has restrictions on its availability to us is classified as restricted cash. Restricted cash represents $16.3 million held in an escrow account as of March 31, 2020 as required by the Centers for Medicare & Medicaid Services (CMS) in conjunction with the Bundled Payments for Care Improvement (BPCI) Advanced Program.
The following table provides a reconciliation of cash, cash equivalents and restricted cash reported within the accompanying consolidated balance sheets that sum to the total of those same amounts presented in the accompanying consolidated statements of cash flows. The restricted cash presented below is classified as non-current in Other assets, net within the accompanying consolidated balance sheets.
|
| | | | | | | |
| March 31, 2020 | | December 31, 2019 |
Cash and cash equivalents | $ | 92,315 |
| | $ | 67,030 |
|
Restricted cash included in Other assets, net | 16,315 |
| | 16,261 |
|
Cash of discontinued operations | 32,363 |
| | 1,396 |
|
Total cash, cash equivalents and restricted cash | $ | 140,993 |
| | $ | 84,687 |
|
Note 2—Fair Value
The carrying amounts of cash and cash equivalents, accounts receivable and accounts payable reported in the consolidated balance sheets approximate fair value due to the short-term nature of these instruments. The carrying amount of restricted cash also approximates fair value due to its nature. The fair value of debt is estimated based on quoted market prices or dealer quotes for the identical liability when traded as an asset in an active market (Level 1) or, if quoted market prices or dealer quotes are not available, on the borrowing rates currently available for loans with similar terms, credit ratings, and average remaining maturities (Level 2). See Note 6 for the fair value of debt. The fair value of interest rate swaps and foreign currency contracts is determined based on the present value of expected future cash flows considering the risks involved, including non-performance risk, and using discount rates appropriate for the respective maturities. Observable Level 2 inputs are used to determine the present value of expected future cash flows. See Note 8 for the fair value of derivatives.
Note 3—Discontinued Operations
On January 16, 2020, we announced our intention to sell our European logistics business, Movianto, to EHDH Holding Group (EHDH), a privately held French company, for cash consideration of $133 million. The Company concluded that the Movianto business met the criteria for discontinued operations as of March 31, 2020 and December 31, 2019, as the intention to sell represented a strategic shift and the criteria for held-for-sale were met. Movianto was previously reported in the Global Solutions segment. The transaction is expected to close in the first half of 2020.
Accordingly, the results of operations from our Movianto business are reported in the accompanying consolidated statements of operations as “Loss from discontinued operations, net of tax” for the quarters ended March 31, 2020 and 2019, and the related assets and liabilities are classified as held-for-sale as of March 31, 2020 and December 31, 2019 in the accompanying balance sheets. We recognized a loss of $9.1 million and $32.1 million in connection with the classification of the related assets and liabilities as held-for-sale as of March 31, 2020 and December 31, 2019, respectively.
The following table summarizes the financial results of our discontinued operations for the three months ended March 31, 2020 and 2019:
|
| | | | | | | | |
| Three Months Ended March 31, | |
| 2020 | | 2019 | |
Net revenue | $ | 122,342 |
| | $ | 110,548 |
| |
Cost of goods sold | 32,106 |
| | 28,745 |
| |
Gross margin | 90,236 |
| | 81,803 |
| |
Distribution, selling, and administrative expenses | 80,953 |
| | 83,044 |
| |
Asset impairment charges | 9,080 |
| | — |
| |
Acquisition-related and exit and realignment charges | 271 |
| | 126 |
| |
Other operating income, net | (461 | ) | | (186 | ) | |
Operating income (loss) | 393 |
| | (1,181 | ) | |
Interest expense, net | 1,720 |
| | 1,640 |
| |
Loss from discontinued operations before income taxes | (1,327 | ) | | (2,821 | ) | |
Income tax provision from discontinued operations | 1,088 |
| | 357 |
| |
Loss from discontinued operations, net of tax | $ | (2,415 | ) | | $ | (3,178 | ) | |
We suspended depreciation and amortization on assets that are held for sale, including right-of-use assets recorded in accordance with ASU No. 2016-02, for the three months ended March 31, 2020.
The assets and liabilities of the discontinued Movianto business reflected on the consolidated balance sheets at March 31, 2020 and December 31, 2019, are as follows:
|
| | | | | | | | |
| March 31, 2020 | | December 31, 2019 | |
Assets of discontinued operations | | | | |
Cash and cash equivalents | $ | 32,363 |
| | $ | 1,396 |
| |
Accounts receivable, net | 78,193 |
| | 78,643 |
| |
Merchandise inventories | 12,979 |
| | 16,058 |
| |
Other current assets | 227,070 |
| | 188,853 |
| |
Current assets of discontinued operations | 350,605 |
| | 284,950 |
| |
Property and equipment, net | 70,730 |
| | 70,976 |
| |
Intangible assets, net | 7,010 |
| | 6,579 |
| |
Other assets, net | 27,248 |
| | 22,165 |
| |
Operating lease assets | 84,202 |
| | 87,425 |
| |
Valuation allowance on disposal group classified as held for sale | (40,385 | ) | | (32,112 | ) | |
Total assets of discontinued operations | $ | 499,410 |
| | $ | 439,983 |
| |
Liabilities of discontinued operations | | | | |
Accounts payable | $ | 68,058 |
| | $ | 53,981 |
| |
Other current liabilities | 191,728 |
| | 182,980 |
| |
Current liabilities of discontinued operations | 259,786 |
| | 236,961 |
| |
Long-term debt, excluding current portion | 2,781 |
| | 5,523 |
| |
Operating lease liabilities, excluding current portion | 69,820 |
| | 76,270 |
| |
Other liabilities | 51,199 |
| | 4,757 |
| |
Total liabilities of discontinued operations | $ | 383,586 |
| | $ | 323,511 |
| |
Assets and liabilities held for sale as of March 31, 2020 and December 31, 2019 are classified as current since we expect the divestiture to be completed within one year of the balance sheet dates.
The following table provides operating and investing cash flow information for our discontinued operations:
|
| | | | | | | | |
| March 31, 2020 | | March 31, 2019 | |
Operating Activities: | | | | |
Depreciation and amortization | $ | — |
| | $ | 5,613 |
| |
Asset impairment charges | 9,080 |
| | — |
| |
Investing Activities: | | | | |
Capital expenditures | 1,664 |
| | 8,035 |
| |
Note 4—Goodwill and Intangible Assets
The following table summarizes the goodwill balances by segment and the changes in the carrying amount of goodwill through March 31, 2020:
|
| | | | | | | | | | | |
| Global Solutions | | Global Products | | Consolidated |
Carrying amount of goodwill, December 31, 2019 | $ | 283,905 |
| | $ | 109,276 |
| | $ | 393,181 |
|
Currency translation adjustments | — |
| | (5,181 | ) | | (5,181 | ) |
Carrying amount of goodwill, March 31, 2020 | $ | 283,905 |
| | $ | 104,095 |
| | $ | 388,000 |
|
Intangible assets at March 31, 2020 and December 31, 2019, were as follows:
|
| | | | | | | | | | | | | | | | | | | | | | | |
| March 31, 2020 | | December 31, 2019 |
| Customer Relationships | | Tradenames | | Other Intangibles | | Customer Relationships | | Tradenames | | Other Intangibles |
| | | | | | | | | | | |
Gross intangible assets | $ | 266,595 |
| | $ | 90,000 |
| | $ | 43,227 |
| | $ | 270,693 |
| | $ | 90,000 |
| | $ | 43,055 |
|
Accumulated amortization | (97,366 | ) | | (18,611 | ) | | (12,332 | ) | | (92,947 | ) | | (16,520 | ) | | (9,263 | ) |
Net intangible assets | $ | 169,229 |
| | $ | 71,389 |
| | $ | 30,895 |
| | $ | 177,746 |
| | $ | 73,480 |
| | $ | 33,792 |
|
Weighted average useful life | 10 years |
| | 11 years |
| | 8 years |
| | 10 years |
| | 11 years |
| | 8 years |
|
At March 31, 2020, $76.1 million in net intangible assets were held in the Global Solutions segment and $195.4 million were held in the Global Products segment. Amortization expense for intangible assets was $10.6 million and $10.0 million for the three months ended March 31, 2020 and 2019, respectively.
Based on the current carrying value of intangible assets subject to amortization, estimated amortization expense is $31.1 million for the remainder of 2020, $39.8 million for 2021, $38.9 million for 2022, $38.7 million for 2023, $33.9 million for 2024 and $28.2 million for 2025.
Note 5—Exit and Realignment Costs
We periodically incur exit and realignment and other charges associated with optimizing our operations which includes the consolidation of certain distribution and outsourced logistics centers, administrative offices and warehouses, and IT restructuring charges. These charges also include costs associated with our strategic organizational realignment which include management changes, certain professional fees, and costs to streamline administrative functions and processes.
Exit and realignment charges by segment for the three months ended March 31, 2020 and 2019 were as follows:
|
| | | | | | | | |
| Three Months Ended March 31, | |
| 2020 | | 2019 | |
Global Solutions segment | $ | 1,829 |
| | $ | 566 |
| |
Global Products segment | — |
| | 138 |
| |
Total exit and realignment charges | $ | 1,829 |
| | $ | 704 |
| |
The following table summarizes the activity related to exit and realignment cost accruals through March 31, 2020 and 2019:
|
| | | | |
| | Total (1) |
Accrued exit and realignment costs, December 31, 2019 | | $ | 8,162 |
|
Provision for exit and realignment activities: | |
|
|
Severance | | 1,391 |
|
Information system restructuring costs | | 183 |
|
Other | | 255 |
|
Change in estimate | | — |
|
Cash payments | | (5,799 | ) |
Accrued exit and realignment costs, March 31, 2020 | | $ | 4,192 |
|
| | |
Accrued exit and realignment costs, December 31, 2018 | | $ | 7,477 |
|
Provision for exit and realignment activities: | | |
Severance | | 360 |
|
Information system restructuring costs | | 261 |
|
Other | | 83 |
|
Change in estimate | | — |
|
Cash payments | | (2,206 | ) |
Accrued exit and realignment costs, March 31, 2019 | | $ | 5,975 |
|
(1)The accrued exit and realignment costs at March 31, 2020 and 2019 related primarily to information system restructuring costs and severance.
Acquisition-related and exit and realignment charges presented in our consolidated statements of operations includes acquisition-related charges of $4.2 million for the three months ended March 31, 2020 and 2019, respectively, and consisted primarily of transition costs for the Halyard acquisition.
Note 6—Debt
Debt consists of the following:
|
| | | | | | | | | | | | | | | |
| March 31, 2020 | | December 31, 2019 |
| Carrying Amount | | Estimated Fair Value | | Carrying Amount | | Estimated Fair Value |
3.875% Senior Notes, due September 2021 | $ | 231,764 |
| | $ | 223,367 |
| | $ | 236,234 |
| | $ | 229,356 |
|
4.375% Senior Notes, due December 2024 | 274,041 |
| | 184,140 |
| | 273,978 |
| | 212,086 |
|
Term A Loans, due July 2022 | 217,924 |
| | 221,906 |
| | 377,420 |
| | 383,050 |
|
Term B Loan, due April 2025 | 479,332 |
| | 340,751 |
| | 480,337 |
| | 442,217 |
|
Revolver | 171,700 |
| | 171,700 |
| | 177,900 |
| | 177,900 |
|
Accounts Receivable Securitization Program | 147,209 |
| | 150,000 |
| | — |
| | — |
|
Finance leases and other | 13,557 |
| | 13,557 |
| | 13,783 |
| | 13,783 |
|
Total debt | 1,535,527 |
| | 1,305,421 |
| | 1,559,652 |
| | 1,458,392 |
|
Less current maturities | (51,187 | ) | | (51,187 | ) | | (51,237 | ) | | (51,237 | ) |
Long-term debt | $ | 1,484,340 |
| | $ | 1,254,234 |
| | $ | 1,508,415 |
| | $ | 1,407,155 |
|
We have $233 million of 3.875% senior notes due 2021 (the “2021 Notes”) and $275 million of 4.375% senior notes due 2024 (the “2024 Notes”), with interest payable semi-annually. The 2021 Notes were sold at 99.5% of the principal amount with an effective yield of 3.951%. The 2024 Notes were sold at 99.6% of the principal with an effective yield of 4.422%. We have the option to redeem the 2021 Notes and 2024 Notes in part or in whole prior to maturity at a redemption price equal to the greater of 100% of the principal amount or the present value of the remaining scheduled payments discounted at the Treasury Rate plus 30 basis points. We used $4.4 million of cash to repurchase $4.6 million aggregate principal amount of the 2021 Notes during the first quarter of 2020.
We have a Credit Agreement (amended February 2020) with a borrowing capacity of $400 million and $697 million outstanding in term loans. On February 13, 2020, we entered into a Fifth Amendment to the Credit Agreement.
The interest rate on our revolving credit facility and Term A loans is based on the Eurocurrency Rate, the Federal Funds Rate or the Prime Rate, plus an adjustment based on our Consolidated Total Leverage Ratio as defined by the Credit Agreement. Our credit spread at March 31, 2020 was Eurocurrency Rate plus 4.25%. Our Term B loan accrues interest based on the Eurocurrency Rate, the Federal Funds Rate or the Prime Rate, plus interest rate margin of 3.50% per annum with respect to Base Rate Loans (as defined in the Credit Agreement), and 4.50% per annum with respect to Eurocurrency Rate Loans (as defined in the Credit Agreement). We are charged a commitment fee of between 12.5 and 25.0 basis points on the unused portion of the facility. The terms of the Credit Agreement requires us to maintain ratios for leverage and interest coverage, including on a pro forma basis in the event of an acquisition.
We also have a Security and Pledge Agreement (the Security Agreement) pursuant to which we granted collateral on behalf of the holders of the 2021 Notes and the 2024 Notes and parties secured on the Credit Agreement (the Secured Parties) including first priority liens and security interests in (a) all present and future shares of capital stock owned by the Credit Parties (as defined) in the Credit Parties’ present and future subsidiaries (limited, in the case of controlled foreign corporations, to a pledge of 100% of the voting capital stock of each first-tier foreign subsidiary of each Credit Party) and (b) all present and future personal property and assets of the Credit Parties, subject to certain exceptions. The Fifth Amendment to the Credit Agreement included additional collateral requirements related to the parties secured on the Credit Agreement, including the obligation to pledge the Company's owned U.S. real estate and remaining equity interests in foreign subsidiaries. Our Credit Agreement has a “springing maturity date” with respect to the revolving loans and the Term A loans and the Term B loans. If as of the date 91 days prior to the maturity date of our 2021 Notes all outstanding amounts under the 2021 Notes have not been paid in full, then the Termination Date (as defined in the Credit Agreement) of the revolving credit facility and the Term A loans shall be the date that is 91 days prior to the maturity date of the 2021 Notes. Likewise, if as of the date 91 days prior to the maturity date of our 2024 Notes, all outstanding amounts under the 2024 Notes have not been paid in full, the Termination Date of the Term B loan shall be the date that is 91 days prior to the maturity date of the 2024 Notes.
On February 19, 2020, we entered into an accounts receivable securitization program (the “Receivables Securitization Program”). Pursuant to the Receivables Securitization Program, the aggregate principal amount of the loans made by the Lenders (as defined) will not exceed $325 million outstanding at any time. The interest rate under the Receivables Securitization Program is based on a spread over the London Interbank Offered Rate (LIBOR) dependent on the tranche period thereto and any breakage fees accrued. Under the Receivables Securitization Program, certain of our subsidiaries sell substantially all of their accounts receivable balances to our wholly owned special purpose entity, O&M Funding LLC. The Receivables Securitization Program matures on February 17, 2023. In February 2020, $150 million in proceeds from the sale of accounts receivable pursuant to the Receivables Securitization Program were used to repay higher interest indebtedness under our Term A loans.
At March 31, 2020 and December 31, 2019, we had borrowings of $171.7 million and $177.9 million, respectively, under the revolver and letters of credit of $11.7 million and $11.7 million, respectively, outstanding under the Credit Agreement along with $508.1 million and $512.7 million, respectively, in Senior Notes. At March 31, 2020 and December 31, 2019, we had $215.5 million and $209.3 million, respectively, available for borrowing, which reflected the letters of credit associated with discontinued operations of $1.1 million and $1.1 million, respectively, against our borrowing capacity. We also had letters of credit and bank guarantees outstanding for $1.5 million as of March 31, 2020 and December 31, 2019, respectively, which supports certain facilities leased as well as other normal business activities in the United States and Europe.
The Credit Agreement and Senior Notes contain cross-default provisions which could result in the acceleration of payments due in the event of default of either agreement. We believe we were in compliance with our debt covenants at March 31, 2020.
As of March 31, 2020, scheduled future principal payments of debt were $37.2 million in 2020, $282.8 million in 2021, $320.5 million in 2022, $155.0 million in 2023, $280.0 million in 2024, and $468.8 million thereafter.
Note 7—Retirement Plans
We have a noncontributory, unfunded retirement plan for certain retirees in the United States. Certain of our foreign subsidiaries also have defined benefit pension plans covering substantially all of their respective employees.
The components of net periodic benefit cost for the three months ended March 31, 2020 and 2019, respectively, were as follows:
|
| | | | | | | |
| Three Months Ended March 31, |
| 2020 | | 2019 |
Service cost | $ | 351 |
| | $ | 329 |
|
Interest cost | 494 |
| | 600 |
|
Recognized net actuarial loss | 214 |
| | 260 |
|
Net periodic benefit cost | $ | 1,059 |
| | $ | 1,189 |
|
Note 8—Derivatives
We are directly and indirectly affected by changes in foreign currency, which may adversely impact our financial performance and are referred to as “market risks.” When deemed appropriate, we use derivatives as a risk management tool to mitigate the potential impact of certain market risks. We do not enter into derivative financial instruments for trading purposes.
We enter into foreign currency contracts to manage our foreign exchange exposure related to certain balance sheet items that do not meet the requirements for hedge accounting. These derivative instruments are adjusted to fair value at the end of each period through earnings. The gain or loss recorded on these instruments is substantially offset by the remeasurement adjustment on the foreign currency denominated asset or liability.
We pay interest under our Credit Agreement which fluctuates based on changes in our benchmark interest rates. In order to mitigate the risk of increases in benchmark rates, we enter into interest rate swaps whereby we agree to exchange with the counterparty, at specified intervals, the difference between fixed and variable amounts calculated by reference to the notional amount. The interest rate swaps were designated as cash flow hedges. Cash flows related to the interest rate swap agreements are included in interest expense.
We determine the fair value of our foreign currency derivatives and our interest rate swaps based on observable market-based inputs or unobservable inputs that are corroborated by market data. We do not view the fair value of our derivatives in isolation, but rather in relation to the fair values or cash flows of the underlying exposure. Our derivatives are over-the-counter instruments with liquid markets. All derivatives are carried at fair value in our consolidated balance sheets in other assets and other liabilities. We consider the risk of counterparty default to be minimal. We report cash flows from our hedging instruments in the same cash flow statement category as the hedged items.
The following table summarizes the terms and fair value of our outstanding derivative financial instruments as of March 31, 2020: |
| | | | | | | | | | | | | | | | | |
| | | | | Derivative Assets | | Derivative Liabilities |
| Notional Amount | | Maturity Date | | Classification | | Fair Value | | Classification | | Fair Value |
Cash flow hedges | | | | | | | | | | | |
Interest rate swaps | $ | 450,000 |
| | May 2022 and May 2025 | | Other assets, net | | $ | — |
| | Other liabilities | | $ | 33,136 |
|
| | | | | | | | | | | |
Economic (non-designated) hedges | | | | | | | | | | | |
Foreign currency contracts | $ | 21,000 |
| | April 2020 | | Other assets, net | | $ | 280 |
| | Other liabilities | | $ | — |
|
The following table summarizes the terms and fair value of our outstanding derivative financial instruments as of December 31, 2019: |
| | | | | | | | | | | | | | | | | |
| | | | | Derivative Assets | | Derivative Liabilities |
| Notional Amount | | Maturity Date | | Classification | | Fair Value | | Classification | | Fair Value |
Cash flow hedges | | | | | | | | | | | |
Interest rate swaps | $ | 450,000 |
| | May 2022 and May 2025 | | Other assets, net | | $ | — |
| | Other liabilities | | $ | 17,436 |
|
The following table summarizes the effect of cash flow hedge accounting on our consolidated statements of operations for the three months ended March 31, 2020:
|
| | | | | | | | | | |
| Amount of Gain/(Loss) Recognized in Other Comprehensive Loss | Location of Gain/(Loss) Reclassified from Accumulated Other Comprehensive Loss into Income | Total Amount of Income/(Expense) Line Items Presented in the Consolidated Statement of Operations in Which the Effects are Recorded | Amount of Gain/(Loss) Reclassified from Accumulated Other Comprehensive Loss into Income |
Interest rate swaps | $ | (16,958 | ) | Interest expense, net | $ | (23,342 | ) | $ | (1,259 | ) |
The amount of ineffectiveness associated with these contracts was immaterial for the periods presented.
For the three months ended March 31, 2020 and 2019, we recognized a loss of $2.7 million and a gain of $0.5 million, respectively, associated with our economic (non-designated) foreign currency contracts.
We recorded the change in fair value of derivative instruments and the remeasurement adjustment of the foreign currency denominated asset or liability in other operating (income) expense, net for our foreign exchange contracts.
Note 9—Income Taxes
The effective tax rate was 48.9% for the three months ended March 31, 2020, compared to 5.8% in the same quarter of 2019. The change in these rates resulted from an income tax benefit of $5.2 million recorded in the first quarter of 2020 associated with the Coronavirus Aid, Relief, and Economic Security (CARES) Act, the mixture of income and losses in jurisdictions in which we operate, and the incremental income tax expense associated with the vesting of restricted stock. The liability for unrecognized tax benefits was $11.7 million at March 31, 2020 and $11.5 million at December 31, 2019. Included in the liability at March 31, 2020 and December 31, 2019 were $3.1 million of tax positions for which ultimate deductibility is highly certain but for which there is uncertainty about the timing of such deductibility.
Note 10—Net Loss per Common Share
The following summarizes the calculation of net loss per common share attributable to common shareholders for the three months ended March 31, 2020 and 2019:
|
| | | | | | | | |
| Three Months Ended March 31, | |
(in thousands, except per share data) | 2020 | | 2019 | |
Weighted average shares outstanding - basic and diluted | 60,571 |
|
| 60,376 |
| |
|
|
|
| |
Loss from continuing operations | $ | (8,909 | ) |
| $ | (10,918 | ) | |
Basic and diluted per share | $ | (0.15 | ) |
| $ | (0.18 | ) | |
|
|
|
|
|
| |
Loss from discontinued operations | $ | (2,415 | ) |
| $ | (3,178 | ) | |
Basic and diluted per share | $ | (0.04 | ) |
| $ | (0.05 | ) | |
|
|
|
|
|
| |
Net loss | $ | (11,324 | ) |
| $ | (14,096 | ) | |
Basic and diluted per share | $ | (0.19 | ) |
| $ | (0.23 | ) | |
Note 11—Accumulated Other Comprehensive Loss
The following table shows the changes in accumulated other comprehensive loss by component for the three months ended March 31, 2020 and 2019:
|
| | | | | | | | | | | | | | | |
| Retirement Plans | | Currency Translation Adjustments | | Derivatives and Other | | Total |
Accumulated other comprehensive loss, December 31, 2019 | $ | (14,691 | ) | | $ | (25,301 | ) | | $ | (12,715 | ) | | $ | (52,707 | ) |
Other comprehensive loss before reclassifications | — |
| | (28,178 | ) | | (16,958 | ) | | (45,136 | ) |
Income tax | — |
| | — |
| | 4,646 |
| | 4,646 |
|
Other comprehensive loss before reclassifications, net of tax | — |
| | (28,178 | ) | | (12,312 | ) | | (40,490 | ) |
Amounts reclassified from accumulated other comprehensive income | 214 |
| | — |
| | 1,259 |
| | 1,473 |
|
Income tax | (44 | ) | | — |
| | (344 | ) | | (388 | ) |
Amounts reclassified from accumulated other comprehensive income, net of tax | 170 |
| | — |
| | 915 |
| | 1,085 |
|
Other comprehensive income (loss) | 170 |
| | (28,178 | ) | | (11,397 | ) | | (39,405 | ) |
Accumulated other comprehensive loss, March 31, 2020 | $ | (14,521 | ) | | $ | (53,479 | ) | | $ | (24,112 | ) | | $ | (92,112 | ) |
|
| | | | | | | | | | | | | | | |
| Retirement Plans | | Currency Translation Adjustments | | Derivatives and Other | | Total |
Accumulated other comprehensive loss, December 31, 2018 | $ | (8,146 | ) | | $ | (32,551 | ) | | $ | (4,915 | ) | | $ | (45,612 | ) |
Other comprehensive loss before reclassifications | — |
| | (4,207 | ) | | (3,649 | ) | | (7,856 | ) |
Income tax | — |
| | — |
| | 808 |
| | 808 |
|
Other comprehensive loss before reclassifications, net of tax | — |
| | (4,207 | ) | | (2,841 | ) | | (7,048 | ) |
Amounts reclassified from accumulated other comprehensive income | 266 |
| | — |
| | 578 |
| | 844 |
|
Income tax | (69 | ) | | — |
| | (150 | ) | | (219 | ) |
Amounts reclassified from accumulated other comprehensive income, net of tax | 197 |
| | — |
| | 428 |
| | 625 |
|
Other comprehensive income (loss) | 197 |
| | (4,207 | ) | | (2,413 | ) | | (6,423 | ) |
Accumulated other comprehensive loss, March 31, 2019 | $ | (7,949 | ) | | $ | (36,758 | ) | | $ | (7,328 | ) | | $ | (52,035 | ) |
We include amounts reclassified out of accumulated other comprehensive loss related to defined benefit pension plans as a component of net periodic pension cost. For the three months ended March 31, 2020 and 2019, we reclassified $0.2 million and $0.3 million, respectively, of actuarial net losses.
Note 12—Segment Information
We periodically evaluate our application of accounting guidance for reportable segments and disclose information about reportable segments based on the way management organizes the enterprise for making operating decisions and assessing performance. We report our business under two segments: Global Solutions and Global Products. The Global Solutions segment includes our United States distribution, outsourced logistics and value-added services business. Global Products manufactures and sources medical surgical products through our production and kitting operations.
We evaluate the performance of our segments based on their operating income excluding intangible amortization, acquisition-related and exit and realignment charges, certain purchase price fair value adjustments, and other substantive items that, either as a result of their nature or size, would not be expected to occur as part of our normal business operations on a regular basis.
Segment assets exclude inter-segment account balances as we believe their inclusion would be misleading and not meaningful. We believe all inter-segment sales are at prices that approximate market.
The following tables present financial information by segment:
|
| | | | | | | | |
| Three Months Ended March 31, | |
| 2020 | | 2019 | |
Net revenue: | | | | |
Segment net revenue | | | | |
Global Solutions | $ | 1,847,593 |
| | $ | 2,123,599 |
| |
Global Products | 391,192 |
| | 347,085 |
| |
Total segment net revenue | 2,238,785 |
| | 2,470,684 |
| |
Inter-segment revenue | | | | |
Global Products | (116,092 | ) | | (119,844 | ) | |
Total inter-segment revenue | (116,092 | ) | | (119,844 | ) | |
Consolidated net revenue | $ | 2,122,693 |
| | $ | 2,350,840 |
| |
| | | | |
Operating income: | | | | |
Global Solutions | $ | 7,691 |
| | $ | 21,642 |
| |
Global Products | 18,571 |
| | 7,724 |
| |
Inter-segment eliminations | 1,169 |
| | 1,746 |
| |
Intangible amortization | (10,611 | ) | | (10,026 | ) | |
Acquisition-related and exit and realignment charges | (6,064 | ) | | (4,863 | ) | |
Other (1) | — |
| | 381 |
| |
Consolidated operating income | $ | 10,756 |
| | $ | 16,604 |
| |
| | | | |
Depreciation and amortization: | | | | |
Global Solutions | $ | 10,636 |
| | $ | 10,500 |
| |
Global Products | 13,277 |
| | 12,607 |
| |
Discontinued operations | — |
| | 5,613 |
| |
Consolidated depreciation and amortization | $ | 23,913 |
| | $ | 28,720 |
| |
| | | | |
Capital expenditures: | | | | |
Global Solutions | $ | 1,032 |
| | $ | 3,341 |
| |
Global Products | 3,017 |
| | 2,903 |
| |
Discontinued operations | 1,664 |
| | 8,035 |
| |
Consolidated capital expenditures | $ | 5,713 |
| | $ | 14,279 | |